Inhibition of TLR4 signaling reduces the risk of neurodegenerative diseases, and up-regulation of anti-inflammatory cytokines associated with LPS hyperresponsiveness can have adverse effects in the brain [37]. Here, TLR4 is linked to neurodegenerative disease.